Lung Cancer Squamous Cell
Showing 9976 - 10000 of >10,000
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Carcinoma, Renal Cell Trial in China (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +3 more
-
Beijing, Beijing, China
- +16 more
Jun 2, 2023
Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +11 more
- Carmustine
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 29, 2021
Circulating Tumor DNA in Pancreatic Cancer UsingPersonalized
Recruiting
- Pancreatic Cancer
- No intervention
-
Kashiwa, JapanNational Cancer Center Hospital East
Sep 12, 2023
Metabolic Syndrome, HEALTHY VOLUNTEERS, Time Restricted Feeding Trial in Amsterdam (Time Restricted Eating, normal diet)
Recruiting
- Metabolic Syndrome
- +4 more
- Time Restricted Eating
- normal diet
-
Amsterdam, NetherlandsAmsterdam UMC location AMC
Jun 1, 2023
Lymphedema Severity on Shoulder Joint Function and Muscle
Recruiting
- Breast Cancer
- Breast Cancer Female
- Lymphedema severity stratification
-
Al Ḩayy Ath Thāmin, Giza, EgyptOutpatient clinic of faculty of physical therapy, Ahram Canadian
Jul 5, 2023
Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing
Recruiting
- Relapsed or Refractory B-cell Lymphoma
- +6 more
-
Beijing, ChinaBeijing Cancer Hospital
Feb 6, 2023
Acute Kidney Disease Trial in Taipei City (Azacitidine, Placebo)
Not yet recruiting
- Acute Kidney Disease
- Azacitidine
- Placebo
-
Taipei City, TaiwanYu Hsiang Chou
May 2, 2022
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or
Terminated
- Ovarian Cancer
- Ovarian Neoplasms
- 18F-EF5 PET/CT scan
- Optional biopsy
-
Vancouver, British Columbia, CanadaBC Cancer Agency - Vancouver Centre
Feb 2, 2022
Sickle Cell Anemia Trial in Santo Domingo (Hydroxyurea, TCD examination)
Active, not recruiting
- Sickle Cell Anemia
- Hydroxyurea
- TCD examination
-
Santo Domingo, Dominican RepublicEncargada del Servicio de Hematología-Oncología Hospital Infanti
Jan 17, 2023
Gastric or Gastroesophageal Cancer Trial in Kawasaki-shi, Chuo-ku (FPA144)
Completed
- Gastric or Gastroesophageal Cancer
-
Kawasaki-shi, Kanagawa, Japan
- +1 more
Jun 13, 2023
Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Venetoclax Oral Tablet
- +2 more
-
Bronx, New YorkMontefiore Einstein Cancer Center
Jul 14, 2022
Metastatic Castration-resistant Prostate Cancer Trial in United States (AMG 340)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- AMG 340
-
San Francisco, California
- +6 more
Jul 14, 2022
Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)
Recruiting
- Fanconi Anemia
- +2 more
- Total Body Irradiation (TBI) (Plan 1)
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 2, 2022
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Morgantown (Busulfan, Fludarabine)
Active, not recruiting
- Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma
-
Morgantown, West VirginiaWest Virginia University Hospitals Mary Babb Randolph Cancer Cen
Apr 6, 2021
Pulmonary Hypertension, Hypersensitivity Pneumonitis Trial in Cairo (Right heart catheter)
Completed
- Pulmonary Hypertension
- Hypersensitivity Pneumonitis
- Right heart catheter
-
Cairo, EgyptKasr alainy school of medicine
Jul 12, 2022
Advanced Malignant Tumors Trial (AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion)
Not yet recruiting
- Advanced Malignant Tumors
- AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion
- (no location specified)
May 11, 2023
Resectable Intrahepatic Cholangiocarcinoma, Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8, Stage I Intrahepatic
Not yet recruiting
- Resectable Intrahepatic Cholangiocarcinoma
- +4 more
- Cisplatin
- +3 more
-
Atlanta, Georgia
- +2 more
Aug 19, 2022
Pleural Effusion, Malignant, Non-small Cell Carcinoma Trial in Seoul (intrapleural docetaxel administration)
Completed
- Pleural Effusion, Malignant
- Non-small Cell Carcinoma
- intrapleural docetaxel administration
-
Seoul, Korea, Republic ofAsan Medical Center
Mar 6, 2019
Multiple Myeloma Trial in Hamburg (allogeneic HSCT)
Completed
- Multiple Myeloma
- allogeneic HSCT
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Sep 1, 2022
Bladder Bank (a Prospective Banking Study)
Recruiting
- Bladder Carcinoma
- Hematuria
- Non-Interventional Study
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 25, 2023
T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma Trial run
Completed
- T-Cell Peripheral Lymphoma
- +3 more
- Rituximab
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 28, 2021
Lung Tumors, Thoracic Tumors, Tumors by Site Trial in Houston (MIMIG System, Indocyanine Green (ICG))
Terminated
- Lung Neoplasms
- +4 more
- MIMIG System
- Indocyanine Green (ICG)
-
Houston, TexasMD Anderson Cancer Center Interventional Radiology Dept.
Sep 10, 2021
Acute Ischemic Stroke Trial (exosomes derived from human induced pluripotent stem cell for injection, a of exosomes derived
Not yet recruiting
- Acute Ischemic Stroke
- exosomes derived from human induced pluripotent stem cell for injection
- a placebo of exosomes derived from human induced pluripotent stem cell for injection
- (no location specified)
Nov 15, 2023